Home/Filings/4/0001144204-16-103777
4//SEC Filing

Biostage, Inc. 4

Accession 0001144204-16-103777

$HRGNCIK 0001563665operating

Filed

May 19, 8:00 PM ET

Accepted

May 20, 8:00 AM ET

Size

5.2 KB

Accession

0001144204-16-103777

Insider Transaction Report

Form 4
Period: 2016-05-19
Transactions
  • Purchase

    Common Stock

    2016-05-19$1.36/sh+18,000$24,40118,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.315 to $1.38, inclusive. The reporting person undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001563665

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 8:00 AM ET
Size
5.2 KB